Severe immune thrombocytopenia possibly elicited by the anti-influenza viral agent peramivir

Internal Medicine

Volumn 53, Issue 20, 2014, Pages 2369-2371

  Harada Shirado, Kayo ^a   Ikeda, Kazuhiko ^a   Furukawa, Miki ^a   Sukegawa, Masumi ^a   Takahashi, Hiroshi ^a   Shichishima Nakamura, Akiko ^a   Ohkawara, Hiroshi ^a   Noji, Hideyoshi ^a   Kawabata, Kinuyo ^a   Saito, Shun Ichi ^a   Ohto, Hitoshi ^a   Ogawa, Kazuei ^a   Takeishi, Yasuchika ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Immune thrombocytopenia (ITP); Influenza virus; Neuraminidase inhibitor; Peramivir

Indexed keywords

IMMUNOGLOBULIN G; PERAMIVIR; PREDNISOLONE; ANTIVIRUS AGENT; CYCLOPENTANE DERIVATIVE; GUANIDINE DERIVATIVE;

ADULT; ARTICLE; BONE MARROW EXAMINATION; CASE REPORT; DISEASE SEVERITY; FATIGUE; FEVER; FLOW CYTOMETRY; HUMAN; IMMUNOLOGICAL PROCEDURES; IMMUNOPATHOLOGY; INFLUENZA A; LYMPHOCYTE STIMULATING TEST; MALE; PETECHIA; RASH; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VIRUS DETECTION; CHEMICALLY INDUCED; IMMUNOLOGY; INFLUENZA VIRUS A; INFLUENZA, HUMAN;

ADULT; ANTIVIRAL AGENTS; CYCLOPENTANES; GUANIDINES; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MALE; PLATELET COUNT; PREDNISOLONE; THROMBOCYTOPENIA;

EID: 84908006837     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.2330     Document Type: Article

References (18)

1. Birnkrant D, Cox E. The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med 361: 2204-2207, 2010.
2. Kohno S, Yen MY, Cheong HJ, Hirotsu N. Single-intravenous peramivir vs. oral oseltamivir to treat acute, uncomplicated influenza in the outpatient setting: a phase III, randomized, doubleblind trial [abstract]. V-537a. 49th Interscience. Conference. on Antimicrobial. Agents Chemotherapy, 2009.
3. Hu Y, Lu S, Song Z, et al. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 381: 2273-2279, 2013.
4. Background and summary of human infection with influenza A (H7N9) virus- as of 5 April 2013. Available from: http://www. who.int/influenza/human_animal_interface/latest_update_h7n9/en/ index.html
5. Kohno S, Kida H, Mizuguchi M, et al. Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients. Antimicrob Agents Chemother 55: 2803-2812, 2011.
6. Sugaya N, Kohno S, Ishibashi T, Wajima T, Takahashi T. Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection. Antimicrob Agents Chemother 56: 369-377, 2012.
7. Hernandez JE, Adiga R, Armstrong R, et al. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States. Clin Infect Dis 52: 695-706, 2011.
8. Jain S, Fry AM. Peramivir: another tool for influenza treatment? Clin Infect Dis 52: 707-709, 2011.
9. Louie JK, Yang S, Yen C, Acosta M, Schechter R, Uyeki TM. Use of intravenous peramivir for treatment of severe influenza A (H1N 1) pdm09. PLoS ONE 7: e40261, 2012.
10. Sorbello A, Jones SC, Carter W, et al. Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus. Clin Infect Dis 55: 1-7, 2012.
11. Ohto H, Miura S, Ariga H, Ishii T, Fujimori K, Morita S; Collaborative Study Group. The natural history of maternal immunization against fetal platelet alloantigens. Transfus Med 14: 399- 408, 2004.
12. Curtis BR, McFarland JG, Wu GG, Visentin GP, Aster RH. Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex. Blood 84: 176-183, 1994.
13. Wie SH, So BH, Song JY, et al. A comparison of the clinical and epidemiological characteristics of adult patients with laboratoryconfirmed influenza A or B during the 2011-2012 influenza season in Korea: a multi-center study. PLoS ONE 8: e62685, 2013.
14. Mantadakis E, Farmaki E, Thomaidis S, Tsalkidis A, Chatzimichael A. A case of immune thrombocytopenic purpura after influenza vaccination: consequence or coincidence? J Pediatr Hematol Oncol 32: e227-e229, 2010.
15. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113: 2386-2393, 2009.
16. Sukati H, Watson HG, Urbaniak SJ, Barker RN. Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpura. Blood 109: 4528-4538, 2007.
17. Kuwana M, Kaburaki J, Kitasato H, Miyako K. Immuodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. Blood 98: 130-139, 2001.
18. Weinberger I, Rotenberg Z, Fuchs J, Ben-Sasson E, Agmon J. Amiodarone-induced thrombocytopenia. Arch Intern Med 147: 735-736, 1987.